Cargando…
Histidyl-Proline Diketopiperazine Isomers as Multipotent Anti-Alzheimer Drug Candidates
Cyclic dipeptides administered by both parenteral and oral routes are suggested as promising candidates for the treatment of neurodegeneration-related pathologies. In this study, we tested Cyclo (His-Pro) isomers (cHP1-4) for their anti-Alzheimer potential using a differentiated human neuroblastoma...
Autores principales: | Turkez, Hasan, Cacciatore, Ivana, Arslan, Mehmet Enes, Fornasari, Erika, Marinelli, Lisa, Di Stefano, Antonio, Mardinoglu, Adil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277666/ https://www.ncbi.nlm.nih.gov/pubmed/32397415 http://dx.doi.org/10.3390/biom10050737 |
Ejemplares similares
-
Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer’s Disease Treatment
por: Yıldırım, Özge Çağlar, et al.
Publicado: (2022) -
Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease
por: Turkez, Hasan, et al.
Publicado: (2021) -
Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration
por: Cinici, Emine, et al.
Publicado: (2021) -
Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents
por: Gouleni, Niki, et al.
Publicado: (2023) -
Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives
por: Turkez, Hasan, et al.
Publicado: (2022)